Due to the ever-increasing amount of electronic waste (e-waste) worldwide, the problem of the effective disposal of printed circuit board waste (WPCB), which are environmentally hazardous, difficult to recycle and economically valuable products, has become a major environmental challenge. Conventional WPCB recycling techniques have low efficiency and require tough processing, such as heat treatment and high pressure. This paper presents a new composite material for the manufacture of printed circuit boards (PCB) that can be easily recycled into their original components and reused. In addition, the most valuable PCB components (electronic components containing precious metals) can be easily separated from the printed circuit board and reused. This study demonstrates the benefit of using biodegradable polymers as binders for PCBs in terms of environmentally friendly and efficient recycling.

Polymer-based bioactive composites are one of the most rapidly advancing areas in contemporary regenerative medicine. This review aims to identify major trends and knowledge gaps in the development of bioactive polymer composites and examine their translational relevance from a materials design perspective, with a specific focus on synthetic thermoplastic polymer matrices suitable for load-bearing bone scaffold applications and filament-based additive manufacturing. A total of 546 publications spanning 2016–2025 were screened, with 106 selected according to predefined relevance criteria. Bibliometric and content analyses were performed to delineate the primary research trajectories of bioactive composite materials. The results revealed that the majority of studies focused on composites comprising synthetic aliphatic polyesters, primarily polylactic acid (PLA) or polycaprolactone (PCL), reinforced with hydroxyapatite (HA) or bioactive glass (BG), which confer osteoconductivity but rarely achieve multifunctionality. Antimicrobial agents, ion-releasing components, and naturally derived bioactive molecules—associated with biointeractive functionalities and reported effects related to osteogenesis, angiogenesis, and immune modulation—are significantly underrepresented. Fewer than 20% of the investigated studies include in vivo validation, underscoring considerable scope for further preclinical and translational research. This work consolidates current trends in synthetic bioactive polymer composite design and identifies critical directions for future research. The findings of this review provide a structured framework to support the selection of composite fabrication and modification strategies, functional additives, and targeted biological functionalities for next-generation, load-bearing bone tissue engineering materials.

Background: Amidst escalating global challenges such as antimicrobial resistance and post-COVID therapeutic gaps, dihydropyrimidines (DHPs) and their thione derivatives have emerged as a highly promising scaffold for drug development. This systematic review aims to consolidate recent advancements (2020–2025) and evaluate the synthetic innovation, structure–activity relationships (SAR), and preclinical potential of these compounds. Methods: A systematic review was conducted according to PRISMA guidelines, searching multiple electronic databases (Scopus, PubMed, Web of Science). Sixty original studies from 2020 to 2025 meeting predefined inclusion criteria were selected for data extraction and qualitative synthesis. Results: The analysis reveals a surge in publications (over 300% since 2020). Key structural modifications, such as N-methylation to improve bioavailability and specific substitutions at C4/C5 positions, significantly enhance biological potency, yielding strong inhibitory effects against viral proteases and cancer cell lines. Notable compounds include the apoptosis inducer LaSOM 65 and multitarget Ru(II)–Biginelli hybrids. Conclusions: This review affirms the timeliness and translational potential of the DHP scaffold. The field shows bright prospects for advancing to phase I trials by 2030, urging intensified exploration to unlock novel pharmaceuticals from this versatile chemotype.

The paper provides experimentally determined thermokinetics of the thermal decomposition of high-viscosity oil (HVO) from the Karazhanbas field, the Republic of Kazakhstan, in the presence of a Fe₃O₄ nanocatalyst, catalytic additives (nickel catalytic additives in microspheres prepared from coal ash), and polymers (such as polyethylene glycol and polystyrene) as hydrogen donors. The HVO decomposition thermokinetics (activation energy, pre-exponential factor, and rate constants), depending on the presence of nanocatalysts, catalytic additives, and/or polymers, were estimated by thermogravimetry methods in an inert nitrogen atmosphere. The experimental data (including HVO weight loss and weight loss rate vs. temperature) and the estimated thermokinetics of HVO decomposition can be used to create a database appropriate for mathematical modeling of the processing of HVO and heavy oil residues.

Background/Objectives: Implant-associated infections remain among the most severe and clinically challenging complications in contemporary orthopedics, largely due to the formation of persistent bacterial biofilms and the limited penetration of systemically administered antibiotics into the tissue–implant interface. In this context, local antibacterial functionalization of implantable materials represents a promising strategy for the prevention of early infectious complications. The objective of this study was to develop and comparatively evaluate the antimicrobial performance of PLA-based composites loaded with antibiotics from different pharmacological classes, with a view toward their potential application in individualized 3D-printed implants. Methods: Polylactic acid (PLA)-based composites incorporating gentamicin, ciprofloxacin, doxycycline, and vancomycin were fabricated using thermal processing under conditions compatible with extrusion and fused filament fabrication. Physicochemical characterization (FTIR, TGA, SEM) was performed to assess the structure and morphology of the composites, and in vitro antibiotic release studies were conducted. Antimicrobial activity was evaluated using an agar diffusion assay against ATCC reference strains and clinical isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus (MSSA and MRSA), Klebsiella pneumoniae, and Pseudomonas aeruginosa (n = 10 per species). The antibacterial performance of the composites was evaluated in comparison with standard commercial antibiotic disks used as qualitative reference controls. Results: Antibiotic-loaded PLA composites exhibited consistent and reproducible antibacterial activity, markedly exceeding that of neat PLA. The broadest activity spectrum was observed for PLA–ciprofloxacin (≈29–36 mm) and PLA–gentamicin (≈25–27 mm), which effectively inhibited both Gram-positive and Gram-negative clinical isolates, including MRSA and P. aeruginosa. PLA–vancomycin retained selective activity against staphylococci (≈14–15 mm), whereas PLA–doxycycline demonstrated limited efficacy against Gram-negative pathogens. Physicochemical analysis confirmed successful incorporation of antibiotics without detectable degradation of the polymer structure, while release studies demonstrated sustained antibiotic release from the composite materials. Importantly, the expected pharmacological activity profiles of the antibiotics were preserved after incorporation into the polymer matrix and subsequent high-temperature processing. Conclusions: The results demonstrate the feasibility of integrating clinically relevant antibiotics into a thermoplastic PLA matrix while preserving their selective antimicrobial activity following processing compatible with extrusion and additive manufacturing. The proposed PLA-based composites can be regarded as elements of a pharmacologically tunable antibacterial platform, offering a rationale for the development of context-dependent, biodegradable, 3D-printed implants for the local prevention of implant-associated infections in the setting of increasing antimicrobial resistance.